Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 1;24(13):10984.
doi: 10.3390/ijms241310984.

Age-Dependent Changes in the Relationships between Traits Associated with the Pathogenesis of Stress-Sensitive Hypertension in ISIAH Rats

Affiliations

Age-Dependent Changes in the Relationships between Traits Associated with the Pathogenesis of Stress-Sensitive Hypertension in ISIAH Rats

Dmitry Yu Oshchepkov et al. Int J Mol Sci. .

Abstract

Hypertension is one of the most significant risk factors for many cardiovascular diseases. At different stages of hypertension development, various pathophysiological processes can play a key role in the manifestation of the hypertensive phenotype and of comorbid conditions. Accordingly, it is thought that when diagnosing and choosing a strategy for treating hypertension, it is necessary to take into account age, the stage of disorder development, comorbidities, and effects of emotional-psychosocial factors. Nonetheless, such an approach to choosing a treatment strategy is hampered by incomplete knowledge about details of age-related associations between the numerous features that may contribute to the manifestation of the hypertensive phenotype. Here, we used two groups of male F2(ISIAHxWAG) hybrids of different ages, obtained by crossing hypertensive ISIAH rats (simulating stress-sensitive arterial hypertension) and normotensive WAG rats. By principal component analysis, the relationships among 21 morphological, physiological, and behavioral traits were examined. It was shown that the development of stress-sensitive hypertension in ISIAH rats is accompanied not only by an age-dependent (FDR < 5%) persistent increase in basal blood pressure but also by a decrease in the response to stress and by an increase in anxiety. The plasma corticosterone concentration at rest and its increase during short-term restraint stress in a group of young rats did not have a straightforward relationship with the other analyzed traits. Nonetheless, in older animals, such associations were found. Thus, the study revealed age-dependent relationships between the key features that determine hypertension manifestation in ISIAH rats. Our results may be useful for designing therapeutic strategies against stress-sensitive hypertension, taking into account the patients' age.

Keywords: ISIAH rat strain; age-related difference; hypertension; principle component analysis; stress reactivity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Principal component analysis performed on the combined group of male F2(ISIAHxWAG) hybrids of different ages. Blue dots: 3–4-month-old rats; red dots: 6–7-month-old rats.
Figure 2
Figure 2
Principal component analysis in groups of F2(ISIAHxWAG) hybrid males of different ages: (a) 3–4 months old; (b) 6–7 months old.
Figure 3
Figure 3
Principal component analysis (of behavioral traits) performed on the combined group of F2(ISIAHxWAG) hybrid males of the two age ranges. Blue dots: 3–4-month-old rats; red dots: 6–7-month-old rats.
Figure 4
Figure 4
Principal component analysis of behavioral traits in groups of F2(ISIAHxWAG) hybrid males of different ages: (a) 3–4 months old; (b) 6–7 months old.
Figure 5
Figure 5
An outline of experimental data collection. BP: blood pressure; Cort.: corticosterone. Days 1–4: open field test; day 8: basal BP measurement; day 15: BP measurement under stress and blood collection for corticosterone quantification under stress; day 22: decapitation, blood collection for basal corticosterone quantification, and body and organ weight measurement.

Similar articles

References

    1. Bozkurt B., Aguilar D., Deswal A., Dunbar S.B., Francis G.S., Horwich T., Jessup M., Kosiborod M., Pritchett A.M., Ramasubbu K., et al. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement from the American Heart Association. Circulation. 2016;134:e535–e578. doi: 10.1161/CIR.0000000000000450. - DOI - PubMed
    1. Hamrahian S.M., Falkner B. Hypertension in Chronic Kidney Disease. Adv. Exp. Med. Biol. 2017;956:307–325. doi: 10.1007/5584_2016_84. - DOI - PubMed
    1. Teck J. Diabetes-Associated Comorbidities. Prim. Care. 2022;49:275–286. doi: 10.1016/j.pop.2021.11.004. - DOI - PubMed
    1. Di Palo K.E., Barone N.J. Hypertension and Heart Failure: Prevention, Targets, and Treatment. Heart Fail Clin. 2020;16:99–106. doi: 10.1016/j.hfc.2019.09.001. - DOI - PubMed
    1. Omote K., Verbrugge F.H., Borlaug B.A. Heart Failure with Preserved Ejection Fraction: Mechanisms and Treatment Strategies. Annu. Rev. Med. 2022;73:321–337. doi: 10.1146/annurev-med-042220-022745. - DOI - PMC - PubMed